All Journals > Clinical Infectious Diseases > 1 March 2006 > HCV Treatment Eligibility among Injection Drug Users

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

1 March 2006

Volume 42, Number 5
Clinical Infectious Diseases 2006;42:669–672
© 2006 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2006/4205-0012$15.00
DOI: 10.1086/499951
BRIEF REPORT

Eligibility for Treatment of Hepatitis C Virus Infection among Young Injection Drug Users in 3 US Cities

Holly Hagan,1

Mary H. Latka,2

Jennifer V. Campbell,3

Elizabeth T. Golub,4

Richard S. Garfein,5

David A. Thomas,4,5

Farzana Kapadia,2 and

Steffanie A. Strathdee,6 for the

Study to Reduce Intravenous Exposures Project Teama

1National Development and Research Institutes, Center for Drug Use and HIV Research, 2New York Academy of Medicine, Center for Urban Epidemiologic Studies, New York; 3Public Health—Seattle & King County, HIV/AIDS Epidemiology, Seattle, Washington; 4Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, and 5School of Medicine, Baltimore, Maryland; and 6University of California at San Diego School of Medicine, Department of Family and Preventive Medicine

Among 404 injection drug users aged 18–35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate‐to‐severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

Received 27 June 2005; accepted 29 September 2005; electronically published 20 January 2006.

Reprints or correspondence: Dr. Holly Hagan, Center for Drug Use and HIV Research, National Development and Research Institutes, 71 W. 23rd Street, 8th Fl., New York, NY 10010 ().

Cited by

Tracy Swan, Jen Curry. (2009) Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: Treating active drug users. Hepatology 50:1, 323-324
Online publication date: 1-Aug-2009.
CrossRef
Kimberly Page-Shafer, Judith A Hahn, Paula J Lum. (2007) Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough. AIDS 21:14, 1967-1969
Online publication date: 1-Oct-2007.
CrossRef
Farzana Kapadia, Mary H. Latka, Holly Hagan, Elizabeth T. Golub, Jennifer V. Campbell, Micaela H. Coady, Richard S. Garfein, David L. Thomas, Sebastian Bonner, Thelma Thiel, Steffanie A. Strathdee. (2007) Design and Feasibility of a Randomized Behavioral Intervention to Reduce Distributive Injection Risk and Improve Health-Care Access Among hepatitisC virus Positive Injection Drug Users: The Study to Reduce Intravenous Exposures (STRIVE). Journal of Urban Health 84:1, 99-115
Online publication date: 17-Feb-2007.
CrossRef
Brian R. Edlin and Michael R. Carden. (2006) Editorial Commentary: Injection Drug Users: The Overlooked Core of the Hepatitis C Epidemic. Clinical Infectious Diseases 42:5, 673-676
Online publication date: 1-Mar-2006.
Citation-Full Text-PDF Version (65 kB)

  • Members of the Study to Reduce Intravenous Exposures (STRIVE) project team are listed at the end of the text.

Back to Top
Close Popup